1st Quarter - Report

CROSSROADS STRATEGIES, LLC for ALKERMES, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to pharmaceutical IP and supply chain.

LobbyistCovered position, as disclosed
JASON GLEASON —
STEWART HALL —
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Drug Pricing; Medicaid rebates and AMP Cap; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes.

LobbyistCovered position, as disclosed
JASON GLEASON —
STEWART HALL —
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1868 (117th), H.R. 1319 (117th)

Health Issues HCR

Advance the use of and access to FDA-approved medications to treat addiction and mental illness in criminal justice and public health settings; pharmaceutical supply chain issues; drug pricing. Implementation of Comprehensive Addiction and Recovery Act of 2016 (P.L.114-198), 21st Century Cures Act (P.L.114-255), SUPPORT for Patients and Communities Act (P.L.115-271), and CARES Act (P.L.116-136). Executive Order on Access to Affordable Life-saving Medications (E.O.13937); Executive Order on Increasing Drug Importation to Lower Prices for American Patients (E.O.13938); Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen (E.O.13939); Executive Orders on Lowering Drug Prices by Putting America First (E.O.13947, E.O.13948); Executive Order on Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States (E.O.13944); Executive Order on An America-First Healthcare Plan (E.O.13951). S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act.

LobbyistCovered position, as disclosed
JASON GLEASON —
STEWART HALL —
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 920 (117th), S. 908 (117th), S. 909 (117th)

Budget/Appropriations BUD

Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings, including SAMHSA funding; FY2022 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act; FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; FY2022 Department of the Interior, Environment, and Related Agencies Appropriations Act; H.R.748, CARES Act (P.L.116-136) implementation; H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).

LobbyistCovered position, as disclosed
JASON GLEASON —
STEWART HALL —
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Bills named: H.R. 748 (117th), H.R. 1319 (117th), H.R. 133 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.